Extubation generates lung volume inhomogeneity in preterm infants - Bhatia, R; Carlisle, HR; Armstrong, RK; Kamlin, COF; Davis, PG; Tingay, DG (medRxiv, 2021)
Objective To evaluate the feasibility of EIT to describe the regional tidal ventilation (VT) and change in end-expiratory lung volume (EELV) patterns in preterm infants during the process of extubation from invasive to non-invasive respiratory support.Design Prospective observational studySetting Single-centre tertiary neonatal intensive care unitPatients Preterm infants born <32 weeks gestation who were being extubated to nasal continuous positive airway pressure (nCPAP) as per clinician discretion.Interventions Electrical Impedance Tomography measurements were taken in supine infants during elective extubation from synchronised positive pressure ventilation (SIPPV) before extubation, during and then at 2 and 20 minutes after commencing nCPAP. Extubation and pressure settings were determined by clinicians.Main outcome measures Global and regional ΔEELV and ΔVT were measured. Heart rate, respiratory rate and oxygen saturation were measured throughout.Results Thirty infants of median (range) 2 (1, 21) days were extubated to a median (range) CPAP 7 (6, 8) cmH2O. SpO2/FiO2 ratio was mean (95% CI) 50 (35, 65) lower 20 minutes after nCPAP compared with SIPPV. EELV was lower at all points after extubation compared to SIPPV, and EELV loss was primarily in the ventral lung (p=0.04). VT was increased immediately after extubation, especially in the central and ventral regions of the lung, but the application of nCPAP returned VT to pre-extubation patterns.Conclusions Lung behaviour during the transition from invasive positive pressure ventilation to CPAP at moderate distending pressures is variable and associated with lung volume loss in the ventral lung.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study is supported by the Victorian Government Operational Infrastructure Support Program (Melbourne, Australia). DGT is supported by a National Health and Medical Research Council Clinical Career Development Fellowship (Grant ID 1053889 and Grant ID 1009287). PGD is supported by an NHMRC Practitioner Fellowship Grant (Grant ID 556600) and Program Grant (Grant ID 384100).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Royal Womens Hospital Human Research Ethics Committee, in accordance with the National Health and Medical Research Council Statement of Ethical Conduct in Human Research (2007).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDe-identified individual participant data, study protocols and statistical analysis codes are available from three months to 23 years following article publication to researchers who provide a methodologically sound proposal, with approval by an independent review committee (learned intermediary). Proposals should be directed to david.tingayatmcri.edu.au to gain access. Data requestors will need to sign a data access or material transfer agreement approved by MCRI.